Clinical Biochemistry Practice Questions

Q: Which cardiac biomarker is the most appropriate choice for the diagnosis of myocardial infarction 10 days after the initial event?

Troponins. **Explanation:** The diagnosis of Myocardial Infarction (MI) relies on the temporal patterns of cardiac biomarkers. **Troponins (specifically Cardiac Troponin I and T)** are the gold standard for diagnosis due to their high sensitivity and specificity. **1. Why Troponins are correct:** Troponins begin to rise 3–6 hours after myocardial injury. While Troponin I remains elevated for **7–10 days**, **Troponin T** can remain elevated for up to **10–14 days**. This prolonged elevation makes them the most appropriate choice for diagnosing a "late" or subacute MI when the patient presents several days after the initial event. **2. Why other options are incorrect:** * **CK-MB:** This isoenzyme rises 4–8 hours after injury but returns to baseline within **48–72 hours**. It is the investigation of choice for diagnosing **re-infarction** but is useless 10 days post-event. * **Myoglobin:** This is the **earliest** marker to rise (1–3 hours) but lacks specificity and returns to normal within **24 hours**. * **LDH (Lactate Dehydrogenase):** Specifically the LDH-1 isoenzyme, it peaks at 3–4 days and returns to normal by day 10–14. While it stays elevated longer than CK-MB, Troponins have replaced it in modern clinical practice due to superior cardiac specificity. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Marker:** Myoglobin. * **Most Specific Marker:** Troponin I. * **Marker for Re-infarction:** CK-MB. * **LDH Flip:** In MI, LDH-1 becomes higher than LDH-2 (normally LDH-2 > LDH-1). * **Troponin T** can be falsely elevated in patients with chronic kidney disease (CKD).

Q: Which of the following tests is done to detect the presence of urobilinogen?

Ehrlich's test. **Explanation** The correct answer is **C. Ehrlich’s test**. **1. Why Ehrlich’s test is correct:** Ehrlich’s reagent contains **p-dimethylaminobenzaldehyde** in concentrated hydrochloric acid. When added to urine containing urobilinogen, it reacts to form a characteristic **cherry-red colored complex**. Urobilinogen is a colorless byproduct of bilirubin reduction by intestinal bacteria; its presence in urine is a sensitive indicator of liver dysfunction or hemolytic anemias. **2. Analysis of Incorrect Options:** * **A. Guthrie test:** This is a semi-quantitative bacterial inhibition assay used for neonatal screening of **Phenylketonuria (PKU)**. It detects elevated levels of phenylalanine in the blood. * **B. Fouchet's test:** This test is used to detect **Bile Pigments (Bilirubin)** in urine. Ferric chloride in Fouchet’s reagent oxidizes bilirubin to biliverdin, producing a green/blue color. * **D. Alcian blue spot test:** This is a screening test used to detect **Mucopolysaccharides (Glycosaminoglycans)** in urine, typically used when investigating Mucopolysaccharidoses (e.g., Hurler syndrome). **3. Clinical Pearls for NEET-PG:** * **Fresh Urine Requirement:** Ehrlich’s test must be performed on a fresh urine sample because urobilinogen is rapidly oxidized to urobilin (which does not react with the reagent) upon exposure to air and light. * **Differential Diagnosis:** * **Hemolytic Jaundice:** Urinary urobilinogen is **increased** (increased heme breakdown). * **Obstructive Jaundice:** Urinary urobilinogen is **absent** (bile cannot reach the gut for conversion). * **False Positives:** Porphobilinogen (PBG) also reacts with Ehrlich’s reagent. The **Watson-Schwartz test** is used to differentiate between the two (urobilinogen is soluble in chloroform, while PBG is not).

Q: Cystatin C is a novel marker of?

Glomerular filtration. **Explanation:** **Cystatin C** is a low-molecular-weight protein (13 kDa) produced at a constant rate by all nucleated cells in the body. It belongs to the cysteine protease inhibitor family. It is freely filtered by the **glomerulus**, is not secreted by the renal tubules, and although it is reabsorbed and metabolized by proximal tubular cells, it does not re-enter the blood. Therefore, its serum concentration is inversely proportional to the **Glomerular Filtration Rate (GFR)**. **Why Option C is correct:** Unlike Creatinine, Cystatin C levels are independent of muscle mass, age, gender, or dietary intake (protein consumption). This makes it a more sensitive and reliable marker for detecting early changes in GFR, particularly in the "creatinine-blind" range (mild to moderate renal impairment). **Why other options are incorrect:** * **A. Fatty Liver:** Markers for fatty liver (NAFLD) typically include ALT, AST, and imaging/fibroscan results, not Cystatin C. * **B. Vitamin K Status:** This is assessed via Prothrombin Time (PT/INR) or PIVKA-II levels. * **D. Cholestasis:** This is characterized by elevations in Alkaline Phosphatase (ALP), Gamma-Glutamyl Transferase (GGT), and Conjugated Bilirubin. **High-Yield Clinical Pearls for NEET-PG:** * **Superiority:** Cystatin C is superior to Serum Creatinine in patients with liver cirrhosis, extreme malnutrition, or amputations where muscle mass is significantly reduced. * **Limitation:** Its levels can be affected by thyroid dysfunction (increased in hyperthyroidism) and high-dose corticosteroid therapy. * **Pediatrics:** It is particularly useful in pediatric populations where muscle mass varies significantly with growth.

Q: The xylose absorption test is used to assess:

Monosaccharide absorption. **Explanation:** The **D-xylose absorption test** is a classic diagnostic tool used to evaluate the integrity of the proximal small intestinal mucosa and to differentiate between different causes of malabsorption. **Why the correct answer is right:** D-xylose is a **pentose monosaccharide** that is absorbed via passive diffusion in the proximal small intestine. Unlike complex carbohydrates, it does not require pancreatic enzymes (amylase) or bile salts for digestion. Therefore, if D-xylose levels are low in the blood or urine after oral administration, it indicates **mucosal damage** (e.g., Celiac disease, Tropical sprue) rather than pancreatic insufficiency. It specifically tests the capacity of the intestine to absorb monosaccharides. **Why the other options are incorrect:** * **Insulinoma:** This is a pancreatic islet cell tumor causing hypoglycemia due to excessive insulin secretion. Diagnosis involves the 72-hour fast and C-peptide levels. * **Atypical Carcinoid:** Carcinoid tumors are neuroendocrine tumors secreting serotonin. Diagnosis involves measuring 5-HIAA in urine. * **Zollinger-Ellison Syndrome (ZES):** ZES is caused by a gastrinoma leading to excessive gastric acid. While ZES can cause secondary malabsorption due to acid-induced inactivation of pancreatic enzymes, the D-xylose test is not the primary diagnostic tool (Secretin stimulation test is used). **NEET-PG High-Yield Pearls:** * **Normal Result:** High urinary excretion of D-xylose (>4g in 5 hours) suggests the intestinal mucosa is intact (points toward Pancreatic Insufficiency if malabsorption is present). * **Abnormal Result:** Low urinary excretion suggests **Mucosal disease** (e.g., Celiac disease). * **False Positives:** Low urinary D-xylose can occur in **Renal failure**, **Ascites**, or **Small Intestinal Bacterial Overgrowth (SIBO)** (bacteria metabolize the xylose before absorption).

Q: Why is Troponin C not used for myocardial infarction diagnosis?

Troponin C is present in both cardiac and smooth muscle.. **Explanation:** The diagnosis of Myocardial Infarction (MI) relies on the detection of biomarkers that are highly specific to cardiac tissue. The Troponin complex consists of three subunits: **Troponin T (Trop-T)**, **Troponin I (Trop-I)**, and **Troponin C (Trop-C)**. The correct answer is **Option B**. Troponin C is not used clinically because it lacks tissue specificity. While Troponin I and T have unique cardiac isoforms (cTnI and cTnT) that differ from skeletal muscle isoforms, **Troponin C is identical in both cardiac and slow-twitch skeletal muscle**. Therefore, an elevation in Troponin C could indicate either cardiac injury or skeletal muscle damage, making it an unreliable diagnostic tool for MI. **Analysis of Incorrect Options:** * **Option A:** While Troponin C does bind to calcium (initiating contraction), this is its physiological function and not the reason it is excluded as a biomarker. * **Option C:** This is partially true but less precise than the biochemical reality that it is shared specifically with slow-twitch skeletal fibers. However, in the context of standard NEET-PG patterns, the lack of cardiac-specific isoforms is the primary disqualifier. * **Option D:** Troponin C does not necessarily elevate "late"; it is simply not measured because it cannot differentiate the source of muscle injury. **NEET-PG High-Yield Pearls:** * **Gold Standard:** Cardiac Troponins (cTnI and cTnT) are the preferred markers for MI due to high sensitivity and specificity. * **Timeline:** Troponins rise within **3–6 hours**, peak at **12–24 hours**, and remain elevated for **7–10 days** (cTnI) or up to **14 days** (cTnT). * **Re-infarction:** **CK-MB** is the marker of choice for diagnosing a second MI occurring shortly after the first, as it returns to baseline within 48–72 hours.

Q: Which of the following is the biochemical marker of choice for cholestatic jaundice of pregnancy?

Bile acids. **Explanation:** **Intrahepatic Cholestasis of Pregnancy (ICP)** is a reversible form of cholestasis occurring typically in the third trimester, characterized by intense pruritus (especially of palms and soles) without a rash. **Why Bile Acids are the Correct Answer:** The biochemical hallmark and the most sensitive marker for diagnosing and monitoring ICP is the elevation of **Total Serum Bile Acids (TSBA)**. In ICP, there is a defect in the excretion of bile acids into the bile canaliculi, leading to their accumulation in the blood. A level >10 µmol/L is diagnostic, and levels >40 µmol/L are associated with increased fetal risk (preterm birth, meconium staining, and stillbirth). **Why Other Options are Incorrect:** * **Serum Bilirubin:** While it may be elevated in some cases (clinical jaundice), it is an insensitive marker. Most patients with ICP remain non-icteric. * **Bile Salts:** While often used interchangeably in casual conversation, "Bile Acids" is the precise biochemical term used in diagnostic assays. Bile salts are the conjugated form found in the intestine. * **Alkaline Phosphatase (ALP):** ALP levels naturally increase during pregnancy (3-4 times) due to the production of the placental isoenzyme. Therefore, it lacks the specificity required to diagnose cholestasis in a pregnant patient. **Clinical Pearls for NEET-PG:** * **Primary Symptom:** Pruritus (worse at night) without a primary skin rash. * **Treatment of Choice:** **Ursodeoxycholic acid (UDCA)**, which helps lower bile acid levels and relieves itching. * **Fetal Risk:** The main concern is sudden intrauterine fetal death (IUFD) due to bile acid toxicity to the fetal myocardium. * **Resolution:** Symptoms and biochemical markers typically resolve rapidly after delivery.

Q: Microalbuminuria is defined as protein levels of:

30-300 mg/d. **Explanation:** Microalbuminuria refers to the excretion of albumin in the urine at a rate higher than normal but below the detection limit of a standard dipstick test. It is a critical clinical marker for early-stage diabetic nephropathy and cardiovascular risk. **1. Why Option A is Correct:** The standard clinical definition of microalbuminuria is the excretion of **30–300 mg of albumin over a 24-hour period**. In a healthy individual, the glomerular filtration barrier prevents most albumin from entering the filtrate; thus, normal excretion is <30 mg/day. When the barrier begins to fail (often due to hyperglycemia-induced basement membrane damage), levels rise into the 30–300 mg/day range. **2. Why Other Options are Incorrect:** * **Options B and C (100–200 mg/d):** These ranges fall *within* the spectrum of microalbuminuria but do not define its lower or upper limits. They are subsets, not the diagnostic criteria. * **Option D (301–600 mg/d):** Excretion **>300 mg/day** is classified as **Macroalbuminuria** (or overt proteinuria). At this stage, protein becomes detectable on a routine urine dipstick. **Clinical Pearls for NEET-PG:** * **ACR (Albumin-to-Creatinine Ratio):** Since 24-hour collection is cumbersome, a spot urine ACR is preferred. Microalbuminuria is defined as an ACR of **30–300 mg/g**. * **Reversibility:** This stage is clinically significant because it is the last point where renal damage may be reversible with strict glycemic control and ACE inhibitors/ARBs. * **Screening:** In Type 2 Diabetes, screen at the time of diagnosis. In Type 1 Diabetes, screen 5 years after diagnosis.

Question 1

Which cardiac biomarker is the most appropriate choice for the diagnosis of myocardial infarction 10 days after the initial event?

Accepted Answer

Troponins

Answer

CK-MB

Answer

Myoglobin

Answer

LDH

Question 2

Conjugated bilirubin is increased in which of the following conditions?

Accepted Answer

Rotor Syndrome

Answer

Gilbert syndrome

Answer

Crigler-Najjar syndrome type 1

Answer

Crigler-Najjar syndrome type 2

Question 3

Which of the following tests is done to detect the presence of urobilinogen?

Accepted Answer

Ehrlich's test

Answer

Guthrie test

Answer

Fouchet's test

Answer

Alcian blue spot test

Question 4

Cystatin C is a novel marker of?

Accepted Answer

Glomerular filtration

Answer

Fatty liver

Answer

Vitamin K status

Answer

Cholestasis

Question 5

The xylose absorption test is used to assess:

Accepted Answer

Monosaccharide absorption

Answer

Insulinoma

Answer

Atypical carcinoid

Answer

Zollinger-Ellison syndrome

Question 6

Why is Troponin C not used for myocardial infarction diagnosis?

Accepted Answer

Troponin C is present in both cardiac and smooth muscle.

Answer

Troponin C binds to calcium.

Answer

Troponin C is present in both cardiac and skeletal muscle.

Answer

It elevates late after the onset of myocardial infarction.

Question 7

What is the temporal profile of detection of serum enzymes in acute myocardial infarction?

Accepted Answer

CPK, SGOT, LDH

Answer

SGOT, CPK, LDH

Answer

CPK, LDH, SGOT

Answer

SGOT, LDH, CPK

Question 8

Conjugated hyperbilirubinemia is seen in which of the following conditions?

Accepted Answer

Dubin-Johnson syndrome

Answer

Breast milk jaundice

Answer

Crigler-Najjar syndrome

Answer

Gilbert syndrome

Question 9

Which of the following is the biochemical marker of choice for cholestatic jaundice of pregnancy?

Accepted Answer

Bile acids

Answer

Serum Bilirubin

Answer

Bile salts

Answer

Alkaline phosphatase levels

Question 10

Microalbuminuria is defined as protein levels of:

Accepted Answer

30-300 mg/d

Answer

151-200 mg/d

Answer

100-150 mg/d

Answer

301-600 mg/d

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?